DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Butisol (Butabarbital Sodium) - Summary

 


Nutrilib.com
A comprihensive source of nutritional information

BUTISOL SUMMARY

BUTISOL SODIUMŪ CIII

BUTISOL SODIUMŪ (butabarbital sodium tablets, USP and butabarbital sodium oral solution, USP) is a non-selective central nervous system depressant which is used as a sedative or hypnotic. It is available for oral administration as Tablets containing 30 mg or 50 mg butabarbital sodium; and as Oral Solution containing 30 mg/5 mL, with alcohol (by volume) 7%.

BUTISOL SODIUMŪ (butabarbital sodium tablets, USP and butabarbital sodium oral solution, USP) is indicated for use as a sedative or hypnotic.

Since barbiturates appear to lose their effectiveness for sleep induction and sleep maintenance after 2 weeks, use of BUTISOL SODIUMŪ in treating insomnia should be limited to this time (see CLINICAL PHARMACOLOGY).


See all Butisol indications & dosage >>

BUTISOL NEWS HIGHLIGHTS

Media Articles Related to Butisol (Butabarbital)

Health Tip: Treating Insomnia
Source: MedicineNet Sleep Specialty [2008.11.17]

Primary Insomnia Tied to Brain Neurochemical Imbalance
Source: MedicineNet Depression Specialty [2008.11.04]

Primary Insomnia And A Neurochemical Abnormality In Young And Middle-Aged Adults Linked By Study
Source: Sleep / Sleep Disorders / Insomnia News From Medical News Today [2008.11.03]

Primary Insomnia Tied to Brain Neurochemical Imbalance (HealthDay)
Source: Y! Health News Search RSS Feed [2008.11.03]

Insomnia - EMEA Issues Positive Opinion For LUNIVIA(R) (Eszopiclone) Marketing Authorization Application (MAA) In Europe
Source: Sleep / Sleep Disorders / Insomnia News From Medical News Today [2008.10.26]

more >>

Published Studies Related to Butisol (Butabarbital)

Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital. [2003.06]

Comparison of anaesthetic and kinetic properties of thiobutabarbital, butabarbital and hexobarbital after intravenous threshold doses in the male rat. [1989.03]

more >>

Page last updated: 2008-11-17

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008